Reports

Ideas That Generate Results

1. Analyst View

2. Research Methodology

3. Market Drivers & Restraints
     3.1 Biotech Allies with Pharma to Discover Biosimilars
     3.2 Biosimilars Approvals are on the Rise
     3.3 Biogenerics: Market Entry Barriers
     3.4 Rising Interests of Venture Capitalists

4. Industry Performance
     4.1 Market Size
     4.2 Currently Marketed Biosimilars
            4.2.1 Erythropoietin
            4.2.2 Human Growth Hormone
            4.2.3 Recombinant Human Insulin
            4.2.4 G-CSF
            4.2.5 Interferons

5. Major Geographical Market
     5.1 Americas
            5.1.1 US
            5.1.2 Canada
            5.1.3 Mexico
     5.2 EU
     5.3 Asia Pacific
            5.3.1 Korea
            5.3.2 China
            5.3.3 India

6. Regulatory Environment

7. Patent Expirations & Product Approvals

8. Collaborations & Acquisitions

9. Competitive Landscape
     9.1 Teva
     9.2 Sandoz
     9.3 Hospira
     9.4 Mylan
     9.5 Actavis
     9.6 Biocon Ltd.
     9.7 Cipla Ltd.
     9.8 Dr. Reddy's Laboratories Ltd.
     9.9 Wockhardt Ltd.